25.07.2017
- Norway’s Vistin Pharma has agreed to sell its opioids and tablet manufacturing business (CMO) to Australia’s TPI Enterprises for 100 million Norwegian krone ($12.5 million). On the...
29.04.2013
- Pfizer and Merck & Co said they will co-develop Pfizer's experimental type 2 diabetes drug ertugliflozin, both as a standalone product and in combination with other drugs...
